Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) Price & Performance

Alnylam Pharmaceuticals, Inc.Trade
Direxion Daily 20 Year Treasury Bull 3X SharesTrade

Price performance (Past 24H)

Key statistics

Alnylam Pharmaceuticals, Inc. vs Direxion Daily 20 Year Treasury Bull 3X Shares — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $220.35 (market cap $29.60B), while Direxion Daily 20 Year Treasury Bull 3X Shares trades at $31.05. Which is the better fit depends on your goals.

ALNYTMF
Market Cap
$29.60B
Sector
HealthLeveraged / Inverse
52-Week High
$491.22$44.14
52-Week Low
$205.48$30.59
Enterprise Value
$27.56B

Returns comparison

Trailing returns across standard periods

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.

Read more on ALNY

About Direxion Daily 20 Year Treasury Bull 3X Shares

TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.

Read more on TMF